Contrast-enhanced breast MRI may help rule out malignancy and avoid surgery in patients with high-risk lesions, a systematic review and meta-analysis reveals.
According to the ARRS American Journal of Roentgenology (AJR), contrast-enhanced mammography (CEM) may be a useful alternative test for neoadjuvant therapy (NAT) response assessment in patients with ...
CHICAGO--(BUSINESS WIRE)--Contrast-enhanced ultrasound (CEUS) is more accurate and reliable than MRI for examining certain liver and kidney nodules, according to two new studies published in the ...
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is being used in oncology as a noninvasive method for measuring properties of the tumor microvasculature. There is potential for DCE-MRI ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved Elucirem, a macrocyclic gadolinium-based contrast agent for those aged 2 years and older, ...
Las Vegas, NV / Syndication Cloud / January 23, 2026 / ContrastConnect Key Takeaways CMS has permanently authorized ...
Contrast-enhanced mammography (CEM) may be a useful alternative test for neoadjuvant therapy (NAT) response assessment in patients with breast cancer who are unable to undergo MRI. “After NAT for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results